Download DNB 2016 Dec PAEDIATRICS PAPER 1 Question Paper

FirstRanker.com

FINAL EXAM NATIONAL BOARD OF EXAMINATIONS
DECEMBER 2016

--- Content provided by​ FirstRanker.com ---

Time : 3 hours Max. Marks :100

IMPORTANT INSTRUCTIONS

--- Content provided by‍ FirstRanker.com ---

• This question paper consists of 10 questions divided into Part ‘A’ and Part ‘B’, each part containing 5 questions.
• Answers to questions of Part ‘A’ and Part ‘B’ are to be strictly attempted in separate answer sheet(s) and the main + supplementary answer sheet(s) used for each part must be tagged separately.
• Answers to questions of Part ‘A’ attempted in answer sheet(s) of Part ‘B’ or vice versa shall not be evaluated.
• Answer sheet(s) of Part ‘A’ and Part ‘B’ are not to be tagged together.
• Part ‘A’ and Part ‘B’ should be mentioned only on the covering page of the respective answer sheet(s).

--- Content provided by FirstRanker.com ---

• Attempt all questions in order.
• Each question carries 10 marks.
• Read the question carefully and answer to the point neatly and legibly.
• Do not leave any blank pages between two answers.
• Indicate the question number correctly for the answer in the margin space.

--- Content provided by FirstRanker.com ---

• Answer all the parts of a single question together.
• Start the answer to a question on a fresh page or leave adequate space between two answers.
• Draw table/diagrams/flowcharts wherever appropriate.

PART A

Write short notes on:

--- Content provided by​ FirstRanker.com ---

1. a) Outline the steps involved in the synthesis of Vitamin D. 3+(3+2+2)
   b) A seven year old boy presents with deformities suggestive of rickets. What are the possible causes? Enumerate the investigations for resistant rickets and treatment of hypophosphataemic rickets.
2. Etiopathogenesis and management of septic shock. 5+5
3. a) Measures of central tendency. 3+2+5
   b) Odds Ratio.
   

   --- Content provided by‍ FirstRanker.com ---

   c) Management of raised intracranial tension.
4. Mechanism of action, therapeutic usage with dosages and 3+4+3 adverse effects in children on:
   a) Infliximab.
   b) Gamma globulins.
   c) Pegylated interferons.

--- Content provided by FirstRanker.com ---

5. Management of status epilepticus in children. 10